These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37680560)

  • 21. Mild and moderate to severe early acute kidney injury following cardiac surgery among patients with heart failure and preserved vs. mid-range vs. reduced ejection fraction: A retrospective cohort study.
    Gao Y; Wang C; Li J; Ji B; Wang J; Yan F; Wang Y
    Eur J Anaesthesiol; 2022 Aug; 39(8):673-684. PubMed ID: 35791895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
    Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical characteristics, predictors, and outcomes of heart failure with improved ejection fraction.
    Su K; Li M; Wang L; Tian S; Su J; Gu J; Chen S
    Int J Cardiol; 2022 Jun; 357():72-80. PubMed ID: 35339576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of cardiac I-123-metaiodobenzylguanidine imaging in patients with reduced, mid-range, and preserved left ventricular ejection fraction admitted for acute decompensated heart failure: a prospective study in Osaka Prefectural Acute Heart Failure Registry (OPAR).
    Seo M; Yamada T; Tamaki S; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Abe M; Nakamura J; Yamamoto K; Kayama K; Kawahira M; Tanabe K; Kimura T; Ueda K; Sakamoto D; Sakata Y; Fukunami M
    Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(1):58-66. PubMed ID: 32091079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impact of prior LVEF in patients with heart failure with mildly reduced ejection fraction.
    Schmitt A; Behnes M; Weidner K; Abumayyaleh M; Reinhardt M; Abel N; Lau F; Forner J; Ayoub M; Mashayekhi K; Akin I; Schupp T
    Clin Res Cardiol; 2024 Apr; ():. PubMed ID: 38619579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
    Savarese G; Vedin O; D'Amario D; Uijl A; Dahlström U; Rosano G; Lam CSP; Lund LH
    JACC Heart Fail; 2019 Apr; 7(4):306-317. PubMed ID: 30852236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in the Left Ventricular Ejection Fraction and Outcomes in Hospitalized Heart Failure Patients with Mid-range Ejection Fraction: A Prospective Observational Study.
    Tsukamoto K; Suzuki A; Shiga T; Arai K; Hagiwara N
    Intern Med; 2021 May; 60(10):1509-1518. PubMed ID: 33328410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of left ventricular ejection fraction with contrast-induced nephropathy and mortality following coronary angiography or intervention in patients with heart failure.
    Wang K; Li HL; Bei WJ; Guo XS; Chen SQ; Islam SMS; Chen JY; Liu Y; Tan N
    Ther Clin Risk Manag; 2017; 13():887-895. PubMed ID: 28769566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comorbidities, Fragility, and Quality of Life in Heart Failure Patients With Midrange Ejection Fraction.
    Gastelurrutia P; Lupón J; Moliner P; Yang X; Cediel G; de Antonio M; Domingo M; Altimir S; González B; Rodríguez M; Rivas C; Díaz V; Fung E; Zamora E; Santesmases J; Núñez J; Woo J; Bayes-Genis A
    Mayo Clin Proc Innov Qual Outcomes; 2018 Jun; 2(2):176-185. PubMed ID: 30225447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline characteristics of 547 new onset heart failure patients in the PREFERS heart failure study.
    Linde C; Ekström M; Eriksson MJ; Maret E; Wallén H; Lyngå P; Wedén U; Cabrera C; Löfström U; Stenudd J; Lund LH; Persson B; Persson H; Hage C;
    ESC Heart Fail; 2022 Aug; 9(4):2125-2138. PubMed ID: 35403374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical characteristics of heart failure with recovered ejection fraction].
    Luo Y; Chai K; Cheng YL; Zhu WR; Li YY; Wang H; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Apr; 49(4):333-339. PubMed ID: 33874682
    [No Abstract]   [Full Text] [Related]  

  • 33. [Impact of different types of heart failure on long-term renal prognosis in patients with renal insufficiency and heart failure].
    Wang YC; Ye N; Bian WJ; Cheng H
    Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 39(1):1-7. PubMed ID: 36776008
    [No Abstract]   [Full Text] [Related]  

  • 34. Empagliflozin: A Review in Symptomatic Chronic Heart Failure.
    Frampton JE
    Drugs; 2022 Nov; 82(16):1591-1602. PubMed ID: 36374374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular function and coronary microcirculation in patients with mild reduced ejection fraction after STEMI.
    Ma Y; Wang L; Jin W; Zhu T; Liu J; Zhao H; Wang J; Lu M; Cao C; Jiang B
    BMC Cardiovasc Disord; 2022 Sep; 22(1):423. PubMed ID: 36154928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium-glucose co-transporter 2 inhibitors in heart failure with mildly reduced or preserved ejection fraction: an updated systematic review and meta-analysis.
    Wang Y; Gao T; Meng C; Li S; Bi L; Geng Y; Zhang P
    Eur J Med Res; 2022 Dec; 27(1):314. PubMed ID: 36581880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and clinical characteristics of sleep-disordered breathing in patients with heart failure of different left ventricular ejection fractions.
    Wang T; Yu FC; Wei Q; Chen L; Xu X; Ding N; Tong JY
    Sleep Breath; 2023 Mar; 27(1):245-253. PubMed ID: 35394577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left Ventricular Ejection Fraction (EF) of 55% as Cutoff for Late Transition From Heart Failure (HF) With Preserved EF to HF With Mildly Reduced EF.
    Ueda T; Kawakami R; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Uemura S; Saito Y
    Circ J; 2015; 79(10):2209-15. PubMed ID: 26227392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
    Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM
    Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life in patients with heart failure and improved ejection fraction: one-year changes and prognosis.
    Zamora E; González B; Lupón J; Borrellas A; Domingo M; Santiago-Vacas E; Cediel G; Codina P; Rivas C; Pulido A; Crespo E; Velayos P; Diaz V; Bayes-Genis A
    ESC Heart Fail; 2022 Dec; 9(6):3804-3813. PubMed ID: 35916351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.